The results obtained in this study suggest that plasma S100B levels are significantly decreased in MDD patients and that its expression is influenced by gender, which may be related to pathological alterations in astrocytes, different pathogeneses of MDD in different genders, and different brain maturation patterns in different genders. Here, S100B is linked to major depressive disorder.